“Re-educating” tumor-associated macrophages by targeting NF-κB
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The nuclear factor κB (NF-κB) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-κB in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive “alternative” phenotype that requires IκB kinase β–mediated NF-κB activation. When NF-κB signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a “classically” activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-κB signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to “re-educate” the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/741fab83e5184295af0f590a594611ed/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-1.jpg)
![Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/2ca0616e0f4f417d8bd81ac7dc101f6c/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Self-citationColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Cited by
Items 601–700 of 802
Laberiano-Fernández, C., Baldavira, C. M., Rúgolo, J. R. M., Tamegnon, A., Pandurengan, R. K., Ab’Saber, A. M., Balancin, M. L., Takagaki, T. Y., Nagai, M. A., Capelozzi, V. L., et al. (2023) · Cancers · doi:10.3390/cancers15215116 · Cited by 10
“Nevertheless, specific subsets of TAMs have biological functions, including cytotoxicity and antigen presentation, that are vital at tumor sites [37].”
BackgroundZhang, Q., Chen, R., Shi, L., Zhao, H., Yin, F., Yu, C., Wang, Y., & Lu, P. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110936 · Cited by 10
“Silencing IL1R in macrophages has been reported to induce polarisation toward the M1 phenotype of macrophages (Hagemann et al., 2008).”
He, Y., Yu, F., Tian, Y., Hu, Q., Wang, B., Wang, L., Hu, Y. W., Tao, Y., Chen, X., & Peng, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.903513 · Cited by 12
“These genes are essential regulators of the direction of macrophage polarization (40, 41).”
BackgroundCao, F., Liu, Y., Cheng, Y., Wang, Y., He, Y., & Xu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-38822-2 · Cited by 10
Cellular and molecular immunology of lung cancer: therapeutic implications
Nguyen, A. H., Berim, I. G., & Agrawal, D. K. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.975692 · Cited by 12
“Inhibition of both the NF-kB inhibitory p50-subunit in human monocytes [98] and the IKKb-dependent NF-kB activation pathway in ovarian cancer cells [99] favors the M1 phenotype response.”
Backgroundde Goede, K. E., Verberk, S. G. S., Baardman, J., Harber, K. J., van Kooyk, Y., de Winther, M. P. J., Schetters, S. T. T., & den Bossche, J. V. (2021) · Cancers · doi:10.3390/cancers13123054 · Cited by 10
Epithelial-to-mesenchymal transition in the development of adenomyosis
Huang, B., Tsai, H., Wang, P., Twu, N.-F., Yen, M., & Chen, Y. (2015) · Gynecology and Minimally Invasive Therapy · doi:10.1016/j.gmit.2015.05.002 · Cited by 10
Hirota, K., Oishi, Y., Taniguchi, H., Sawachi, K., Inagawa, H., Kohchi, C., Soma, G., & Terada, H. (2010) · PubMed · Cited by 12
Hidden features: CD36/SR-B2, a master regulator of macrophage phenotype/function through metabolism
Chen, Y., Zhang, X., Huang, S., & Febbraio, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468957 · Cited by 11
The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting
Mukherjee, S., Pati, S., Dhar, S., Sarkar, T., Paul, S., Basak, U., Chakraborty, S., & Sa, G. (2025) · Cancer Control · doi:10.1177/10732748251406677 · Cited by 10
Khaleel, E. F., Badi, R. M., Satti, H. H., & Mostafa, D. G. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13288 · Cited by 11
Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors
Bapat, A. S., O’Connor, C. H., & Schwertfeger, K. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-32321-0 · Cited by 12
In Vitro Model of Spontaneous Mouse OSE Transformation
Roberts, P. C., & Schmelz, E. M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_30 · Cited by 8
Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation
Swetha, K. L., Maravajjala, K. S., Li, S., Singh, M. S., & Roy, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01194-7 · Cited by 9
Inflammatory and Innate Immune Cells in Cancer Microenvironment and Progression
Brennecke, P., Allavena, P., Laface, I., Mantovani, A., & Bottazzi, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_2 · Cited by 10
Targeting the Tumor Microenvironment by Immunotherapy: Part 2
Leibovici, J., Itzhaki, O., Huszar, M., & Sinai, J. (2011) · Immunotherapy · doi:10.2217/imt.11.112 · Cited by 8
A20 Controls Macrophage to Elicit Potent Cytotoxic CD4+ T Cell Response
Wang, L., Hong, B., Jiang, X., Jones, L. E., Chen, S., & Huang, X. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048930 · Cited by 8
Laviv, Y., Kasper, B. S., & Kasper, E. M. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0837-9 · Cited by 9
Effects of IL-10 and Th2 cytokines on human Mφ phenotype and response to CSF1R inhibitor
Pradel, L. P., Franke, A., & Ries, C. H. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma0717-282r · Cited by 8
Yu, H.-J., Park, H., Lee, B., & Hahm, D. (2025) · Journal of Immunology Research · doi:10.1155/jimr/5517840 · Cited by 8
“NF-κ B further reinforces this immunosuppressive state by directing macrophage polarization toward an M2-like, low-tumoricidal phenotype that supports tumor growth [72].”
BharathwajChetty, B., Aswani, B. S., Shinde, S. S., Alqahtani, M. S., Abbas, M., Sethi, G., Ma, Z., & Kunnumakkara, A. B. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-025-02554-9 · Cited by 8
Roudi, R., Beikzadeh, B., Beikzadeh, B., Kalantari, S., & Sobhani, N. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03676-9 · Cited by 9
“Similarly, CCL22, often secreted in conjunction with TAM-derived IL-10 and TGF-β, promotes Treg recruitment via CCR4 signaling, enhancing local immunosuppression and reinforcing immune-privileged niches within the tumor [110, 136].”
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
Nolfi, M. D. V., Vecchiotti, D., Flati, I., Verzella, D., Padova, M. D., Alesse, E., Capece, D., & Zazzeroni, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933922 · Cited by 8
Chen, Q., Du, X., Ruan, P., Ye, Y., Zheng, J., & Hu, S. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/5385456 · Cited by 9
Elaidy, S. M., El-Kherbetawy, M. K., Abed, S. Y., Alattar, A., Alshaman, R., Eladl, M. A., Alamri, E. S., balawi, A. N. A., Zaid, A., Elkazaz, A. Y., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16030405 · Cited by 8
Shahar, E., Gorodetsky, R., Gaberman, E., Aizenshtein, E., & Pitcovski, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.083 · Cited by 7
Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation
de la Fuente, M., Langer, R., & Alonso, M. J. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_8 · Cited by 7
The role of CUX1 in antagonizing NF-κB signaling in TAMs
Kühnemuth, B., & Michl, P. (2014) · OncoImmunology · doi:10.4161/onci.28270 · Cited by 7
“reported that inhibition of NF-κB signals specifically in TAMs rendered them cytotoxic to tumor cells concurrently with the acquisition of an M1 phenotype.(10)”
BackgroundActivity and Functions of Tumor-associated Macrophages in Prostate Carcinogenesis
Santoni, M., Liang Cheng, C., Conti, A., Mariani, C., Antonio Lopez-beltran, B., Montironi, R., & Battelli, N. (2017) · European Urology Supplements · doi:10.1016/j.eursup.2017.09.002 · Cited by 7
Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practice
Heidinger, M., Caruso, G., Coelho, R., Stiegeler, N., Petousis, S., Kacperczyk-Bartnik, J. P., Oseledchyk, A., Jacob, F., Kurzeder, C., Heinzelmann-Schwarz, V. A., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105312 · Cited by 6
Intracellular Calcium as a Regulator of Polarization and Target Reprogramming of Macrophages
Pogonyalova, M. Y., Popov, D. Y., & Vinokurov, A. Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411901 · Cited by 9
“Hagemann et al. report that NF-κ B (IKK β ) inhibition, specifically in TAMs, reprograms them to an M1 cytotoxic profile (IL-12 high /Arg1 low /NOS2 high ), restores antitumor activity, and regresses advanced ovarian tumors in vivo [164].”
Macrophages and Tumor Development
Ostrand‐Rosenberg, S., & Sinha, P. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_7 · Cited by 7
Premetastatic milieu explained by TLR4 agonist-mediated homeostatic inflammation
Maru, Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.113 · Cited by 6
Innate Immunity and Inflammation
McKarns, S. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64228-9 · Cited by 6
Seyedi, Z., Hashemzadeh, M. R., Colagar, A. H., & Jaafari, M. R. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.187298 · Cited by 6
Macrophages in the Tumor Microenvironment
Escorcio-Correia, M., & Hagemann, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_18 · Cited by 6
Self-citationThe mendelian randomized study revealed the association of prostatitis with prostate cancer risk
Chen, J., Fan, Y., Shang, K., Li, N., Li, C., & He, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-76355-4 · Cited by 6
Myeloid Hypoxia-Inducible Factors in Inflammatory Diseases
Aragonés, J., Elorza, A., Acosta‐Iborra, B., & Landázuri, M. O. (2011) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v31.i1.10 · Cited by 5
Reimann, M., Schmitt, C. A., & Lee, S. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0770-2 · Cited by 5
“Restoration of an M1/tumor-cytotoxic phenotype in M2-type TAM may also provide therapeutic benefits in some malignancies [51, 52 ], thereby marking pathways regulating the M2-to-M1 transition of TAM, such as SHIP or STA6 signaling, as potential targets for future therapeutic interventions [53, 54].”
BackgroundCK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy
Karmakar, S., Chatterjee, M., Basu, M., & Ghosh, M. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177376 · Cited by 5
Liu, M., Zou, G., Fu, J., Fu, J., Chen, H., Pan, C., Liu, H., & Fu, L. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119935 · Cited by 6
Molecular links between inflammation and cancer
Allavena, P., Germano, G., & Mantovani, A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.018 · Cited by 6
Schirripa, M., Zhang, W., Yang, D., Cao, S., Okazaki, S., Loupakis, F., Berger, M. D., Ning, Y., Miyamoto, Y., Suenaga, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193640 · Cited by 5
Canonical NF-κB signaling in myeloid cells promotes lung metastasis in a mouse breast cancer model
Neumann, T., Canli, Ö., & Greten, F. R. (2018) · Oncotarget · doi:10.18632/oncotarget.24697 · Cited by 6
“Intriguingly, targeting NFκB signaling in macrophages can polarize them towards a more cytotoxic phenotype [49].”
BackgroundWang, N., Zhou, Y., Zuo, Z., Wang, R., Li, J., Han, T., & Yang, B. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-619 · Cited by 5
Measurement of Tumor Cytolysis by Macrophages
Escórcio‐Correia, M., & Hagemann, T. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im1418s92 · Cited by 5
“TAMs also contribute to the persistence of inflammation in the tumor microenvironment due to their production of cytokines such as TNF-α and IL-6, which are known to promote tumor growth (Mantovani et al., 2008).”
BackgroundSelf-citationInnate Immunity in Inflammation
Cignarella, A., & Bolego, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_7 · Cited by 6
Cui, Y., Phuong, K., Abdelfattah, N. S., Temple, H. M., Maiorino, L., Kim, B., Dye, J., Yu, K. K. H., Spranger, S., Irvine, D. J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4674 · Cited by 4
Dynamic immuno-nanomedicines in oncology
Ling, H., Zhang, Q., Luo, Q., Ouyang, D., He, Z., Sun, J., & Sun, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.052 · Cited by 4
Shojaei, M., Frey, B., Putz, F., Fietkau, R., Gaipl, U. S., & Derer, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146574 · Cited by 4
“Major Histocompatibility Complex II (MHC II) molecules, essential for antigen presentation and thus induction of adaptive immune responses, are induced by factors such as lipopolysaccharide (LPS) and interferon-gamma (IFN-γ ) and found to be more highly expressed on M1-like than M2-like cells [27].”
NF-KappaB-Mediated Regulation of Tumour-Associated Macrophages: Mechanisms and Significance
Sica, A., & Mantovani, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_11 · Cited by 4
Kondo, T., Tsunematsu, T., Yamada, A., Arakaki, R., Saitō, M., Otsuka, K., Kujiraoka, S., Ushio, A., Kurosawa, M., Kudo, Y., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.166 · Cited by 4
Putri, D. U., Feng, P., Lin, C., Haryana, S. M., Soesatyo, M. H. N. E., Lee, K., & Han, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-10463-x · Cited by 4
The role of bone marrow microenvironment on CAR‐T efficacy in haematologic malignancies
Gao, D., Hong, F., & He, A. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13273 · Cited by 4
Sawachi, K., Shimada, Y., Taniguchi, H., Hirota, K., Inagawa, H., Kohchi, C., Soma, G., Makino, K., & Terada, H. (2010) · PubMed · Cited by 6
NF-κB and Cancer Therapy Drugs
Motolani, A., Martin, M., Sun, M., & Lu, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00064-5 · Cited by 8
Tumour microenvironment markers in spontaneous and induced incubation of breast cancer biopsies
Сергеевна, Г. Ю., Захарова, Н. Б., & Morozova, O. L. (2021) · Sechenov Medical Journal · doi:10.47093/2218-7332.2021.12.1.50-59 · Cited by 4
Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99
Galadima, M., Kotova, I., Schmidt, R., Pastor, J., Schröder, C., Rodríguez-Gil, J. E., & del Alamo, M. M. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119222 · Cited by 4
“On the other hand, it releases carcinogenic molecules [60] that recruit immune and regulatory cells [61].”
BackgroundAre Exercise and Mitochondrial Antioxidants Compatible in the Treatment of Invasive Breast Cancer?
Goh, J., Pettan-Brewer, C., & Enns, L. C. (2012) · Bioenergetics Open access · doi:10.4172/2167-7662.1000101 · Cited by 5
““Classically activated”, or M1 macrophages, have anti-tumor activity, secreting products that can destroy tumors by activating tumoricidal natural killer cells [26], T-helper (Th)1 cells [27], and upregulate Nuclear Factor (NF)-κB transcription [28] to elicit anti-tumor immune responses.”
BackgroundThe Role of Tumor-Associated Macrophages (TAMs) in Tumor Progression
Schmieder, A., & Schledzewski, K. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_3 · Cited by 4
Polarization of Tumor Milieu: Therapeutic Implications
Szala, S., Jarosz–Biej, M., Cichoń, T., Smolarczyk, R., & Sochanik, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_22 · Cited by 4
“Therapeutic effects were also observed in animals burdened with tumors in which genes encoding NF-κB transcription factors were active [ 41 ] Also, certain proinfl ammatory agents (e.”
BackgroundInnate Immune Cells: Gatekeepers of Endometriotic Lesions Growth and Vascularization
Capobianco, A., Cottone, L., Monno, A., Ferrari, S. M., Panina‐Bordignon, P., Manfredi, A. A., & Rovere, P. Q. (2010) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/228402651000200202 · Cited by 4
Polarized Activation of Macrophages
Galdiero, M. R., Biswas, S. K., & Mantovani, A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_2 · Cited by 6
“In contrast, NF-κB activation also triggers a genetic program necessary for resolution of infl ammation and M2 skewing of tumor-associated macrophages (Lawrence and Gilroy 2007 ; Hagemann et al. 2008 ).”
BackgroundGoossens, P., Rodríguez‐Vita, J., Etzerodt, A., Massé, M., Rastoin, O., Gouirand, V., van Eck, N. J., Ulas, T., Papantonopoulou, O., Bébien, M., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3283707 · Cited by 4
“However, macrophages also posses intrinsic anti-tumor potential, through direct tumoricidal functions and orchestrating anti-tumor immunity, which may be particularly relevant in response to therapy (Bonnotte et al., 2001; Hagemann et al., 2008; Mytar et al., 1999).”
BackgroundMethodInfluentialSelf-citationThe Regulation of the JNK Cascade and Programmed Cell Death by NF-κB: Mechanisms and Functions
Bennett, J., Moretti, M., Thotakura, A. K., Tornatore, L., & Franzoso, G. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_12 · Cited by 3
Nanomodulation and nanotherapeutics of tumor-microenvironment
Dubey, R., Garg, S. S., & Gupta, J. (2022) · OpenNano · doi:10.1016/j.onano.2022.100099 · Cited by 5
Jiang, Q., Lin, F., Li, Z., Duan, H., Jiang, C., Yu, X., Wang, C., Zhang, L., Sun, X., Zha, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-79173-w · Cited by 3
Collery, P., Desmaële, D., Harikrishnan, A., & Veena, V. (2024) · Anticancer Research · doi:10.21873/anticanres.17394 · Cited by 3
“Manganese-bound albumin nano-complexes stimulated pro-inflammatory responses in human-or murine-derived macrophages, reprogrammed TAMs, and inhibited the growth of melanoma tumors in vivo (18).”
Sarcostemma viminale activates macrophages to a pro-inflammatory phenotype
Brestovac, B., Coghlan, O., Jackaman, C., Nelson, D. J., & Townsend, D. (2014) · Comparative Clinical Pathology · doi:10.1007/s00580-014-1988-5 · Cited by 4
“Macrophages are the most abundant immune cell in the peri-tumoural environment (Allavena et al. 2008), and there is increasing evidence that, if appropriately stimulated, they can contribute to tumour eradication (Klimp et al. 2002; Guiducci et al. 2005; Sinha et al. 2005; Hagemann et al. 2008).”
BackgroundRhein alleviates pancreatitis but induces hepatotoxicity via macrophage activation
Liu, H., Di, Y., Yu, Y., Li, P., He, Y., Yu, H., Gao, X., & Pu, W. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120069 · Cited by 3
The Role of Innate Immune Signaling in Regulation of Tumor-Associated Myeloid Cells
Shime, H., Matsumoto, M., & Seya, T. (2015) · Springer eBooks · doi:10.1007/978-4-431-55327-4_3 · Cited by 3
Sica, A., Straus, L., & Allavena, P. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_20 · Cited by 4
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19
Vitali, L., Merlini, A., Galvagno, F., Proment, A., & Sangiolo, D. (2022) · Biomedicines · doi:10.3390/biomedicines10102628 · Cited by 4
Hallam, S. L., & Hagemann, T. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_5 · Cited by 3
Self-citationInteractions between Immune Cells and Tumor Cells
Cho, S. W. (2013) · Journal of Korean Thyroid Association · doi:10.11106/jkta.2013.6.2.96 · Cited by 2
Korkaya, A. K., Fischer, J. L., Peppers, A., Crosson, S. M., Rayamajhi, M., Miao, E. A., Baldwin, A. S., & Bradford, J. W. (2023) · Innate Immunity · doi:10.1177/17534259231205993 · Cited by 3
“It is well known that canonical NF-κ B plays a role in macrophage polarization, 20,32 – 34 so expression of markers associated with classically activated M1 macrophages (iNOS, IL-12) and alternatively activated M2 macrophages (IL-10) was analyzed (Figure 6).”
BackgroundRadiation-induced rescue effect on human breast carcinoma cells is regulated by macrophages
Pathikonda, S., Tian, L., Arava, C. M., Cheng, S. H., & Lam, Y. W. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101936 · Cited by 2
“2020) and are also involved in the commitment of macrophages to their M2 and TAM phenotypes (Hagemann et al. 2008; Sobczak et al. 2020).”
Biomaterials for endometriosis treatment: Design, advances, and prospects
Liu, Y., Tian, L.-N., Wu, Z.-Y., Wang, Z., Khan, M. K., Ding, J., Jia, R., & Wu, F. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.03.034 · Cited by 2
Plant-derived nanoplatforms for precision bioactive delivery: Viral scaffolds in nanomedicine
Cao, W., Wang, H., Xie, S., Xiao, Q., Zhang, J., Ghorbanpour, M., & Meng, X. (2026) · Industrial Crops and Products · doi:10.1016/j.indcrop.2026.123487 · Cited by 2
Role of NF-κB Activation in Macrophages
Lawrence, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_21 · Cited by 4
Self-citationTherapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment
Giordani, A., Poce, G., Consalvi, S., Maramai, S., Saletti, M., Rossi, A., Patrignani, P., Biava, M., & Anzini, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13342-8.00009-0 · Cited by 3
Macrophages morphology and cytokine reeducation by ex situ copper thiol complexes
Xool-Tamayo, J., Arana‐Argáez, V. E., la Torre, F. V.-D., Chan‐Zapata, I., Vargas‐Coronado, R. F., & Cauich‐Rodríguez, J. V. (2023) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2023.2245559 · Cited by 2
“The M1 polarization is related to pathogen response, phagocytosis, proangiogenic myocardial repair, cardiac scar deposition, and inhibition of tumor progression as a cell protector [3,6,10,11].”
BackgroundPathology and tumor microenvironment of vestibular schwannoma
Hannan, C. J., Raghunathan, A., Gompel, J. J. V., & Pathmanaban, O. N. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-12-824534-7.00014-7 · Cited by 3
Tumor-Associated Macrophages and Cancer Development
Isobe, K., & Xiao, H. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_20 · Cited by 2
Role of Tumor‐Associated Macrophages (TAM) in Cancer Related Inflammation
Sica, A., & Porta, C. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch5 · Cited by 2
Inflammatory Dysregulation and Cancer: From Molecular Mechanisms to Therapeutic Opportunities
Steele, C. W., Jamieson, N. B., & Carter, C. R. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_17 · Cited by 2
Hayashi, A., HIROKAWA, Y. S., Kagaya, M., Fujiwara, M., Yoneda, M., Kanayama, K., Uchida, K., Ishii, K., & Shiraishi, T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2402 · Cited by 2
Molecular and Cellular Oncology: A new journal for a changing field
Galluzzi, L., & Kroemer, G. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29052 · Cited by 2
Tumor-Associated Macrophages in Cancer Growth and Progression
Mantovani, A., Allavena, P., & Sica, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50080-8 · Cited by 2
Quantitative assessment of extracellular IL-1 regulation
Ponce, L. F., García‐Martínez, K., & León, K. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110113 · Cited by 2
A New Approach to Cancer Therapy: The Tumor Microenvironment as Target
Schwendener, R. A., & Mete, S. (2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608057986113010003 · Cited by 3
Hanakawa, S., & Kitoh, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55855-2_10 · Cited by 2
The Role of Inflammatory Cells in Tumor Angiogenesis
Tamma, R., Annese, T., & Ribatti, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_14 · Cited by 2
Shahar, E., Gorodetsky, R., Aizenshtein, E., Lalush, L., & Pitcovski, J. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1719-z · Cited by 2
“In spite of the above findings, TAM may still regain cytotoxicity toward tumor cells and switch to a “classically” activated phenotype following “re-education” [15].”
BackgroundKonstantinov, A. S., & Shelekhova, K. V. (2021) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2021-4-80-96 · Cited by 1
CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application
Minina, E. P., Dianov, D. V., Sheetikov, S. A., & Васильевна, Б. А. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050018 · Cited by 1
Li, X., Lin, H., Liang, J., Jin, X., Shen, T., Hu, Y., & Huang, H. (2026) · Nature Reviews Bioengineering · doi:10.1038/s44222-026-00430-w · Cited by 1
Tumor Antigens Revealed by Exome Seqeuncing Drive Editing of Tumor Immunogenicity
Vesely, M. D. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7c8278n · Cited by 2
Tufet, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2365 · Cited by 1
The Tumor Microenvironment as Target for New Cancer Therapies
Schwendener, R. A., & Mete, S. (2014) · Cited by 2
Metadata
- Authors
- Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R.
- Affiliations
- Queen Mary University of London (GB)
- 1Centre for Cancer and Inflammation
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-05-19
- Volume
- 205
- Issue
- 6
- Pages
- 1261-1268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2413024
- OpenAlex
- W2105724560
- Cited by
- 792
- References
- 25
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 32 · 2023: 28 · 2022: 42 · 2021: 41 · 2020: 45 · 2019: 31 · 2018: 50 · 2017: 49 · 2016: 49 · 2015: 46 · 2014: 73 · 2013: 64 · 2012: 41
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- tumor-associated macrophages, NF-κB signaling, macrophage polarization, alternative macrophage activation, IκB kinase β, MyD88, interleukin-1 receptor, IL-12, NK cell recruitment, tumor immunosuppression, tumor microenvironment, antitumor immunity, tumor regression
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Neoplasms, Phenotype, Signal Transduction, NF-kappa B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.